Your browser doesn't support javascript.
loading
Predictive value of 1q21 gain in multiple myeloma is strongly dependent on concurrent cytogenetic abnormalities and first-line treatment.
Minguela, Alfredo; Vasco-Mogorrón, María A; Campillo, José A; Cabañas, Valentin; Remigia, María J; Berenguer, Mercedes; García-Garay, María C; Blanquer, Miguel; Cava, Catalina; Galian, José Antonio; Gimeno, Lourdes; Soto-Ramírez, María F; Martínez-Hernández, María D; de la Rubia, Javier; Teruel, Ana I; Muro, Manuel; Periago, Adela.
Afiliación
  • Minguela A; Immunology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB) Murcia, Spain.
  • Vasco-Mogorrón MA; Immunology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB) Murcia, Spain.
  • Campillo JA; Immunology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB) Murcia, Spain.
  • Cabañas V; Hematology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB) Murcia, Spain.
  • Remigia MJ; Department of Hematology, University Hospital La Fe and School of Medicine and Dentistry, Catholic University of Valencia Valencia, Spain.
  • Berenguer M; Hematology Service, General University Hospital Santa Lucía, Biomedical Research Institute of Murcia (IMIB) Murcia, Spain.
  • García-Garay MC; Hematology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB) Murcia, Spain.
  • Blanquer M; Hematology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB) Murcia, Spain.
  • Cava C; Hematology Service, General University Hospital Rafael Méndez, Biomedical Research Institute of Murcia (IMIB) Murcia, Spain.
  • Galian JA; Immunology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB) Murcia, Spain.
  • Gimeno L; Immunology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB) Murcia, Spain.
  • Soto-Ramírez MF; Human Anatomy Department, Medicine Faculty, Murcia University, Biomedical Research Institute of Murcia (IMIB) Murcia, Spain.
  • Martínez-Hernández MD; Immunology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB) Murcia, Spain.
  • de la Rubia J; Immunology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB) Murcia, Spain.
  • Teruel AI; Department of Hematology, University Hospital La Fe and School of Medicine and Dentistry, Catholic University of Valencia Valencia, Spain.
  • Muro M; Department of Hematology, University Hospital La Fe and School of Medicine and Dentistry, Catholic University of Valencia Valencia, Spain.
  • Periago A; Immunology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB) Murcia, Spain.
Am J Cancer Res ; 11(9): 4438-4454, 2021.
Article en En | MEDLINE | ID: mdl-34659897
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Cancer Res Año: 2021 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Cancer Res Año: 2021 Tipo del documento: Article País de afiliación: España